IL-13 Orchestrates Resolution of Chronic Intestinal Inflammation via Phosphorylation of Glycogen Synthase Kinase-3β

被引:24
作者
Fichtner-Feigl, Stefan [1 ,2 ,3 ]
Kesselring, Rebecca [1 ]
Martin, Maria [1 ]
Obermeier, Florian [4 ]
Ruemmele, Petra [5 ]
Kitani, Atsushi [2 ]
Brunner, Stefan M. [1 ]
Haimerl, Michael [1 ]
Geissler, Edward K. [1 ]
Strober, Warren [2 ]
Schlitt, Hans J. [1 ]
机构
[1] Univ Med Ctr Regensburg, Dept Surg, D-93053 Regensburg, Germany
[2] NIAID, Mucosal Immun Sect, Lab Host Defenses, NIH, Bethesda, MD 20892 USA
[3] Regensburg Ctr Intervent Immunol, D-93053 Regensburg, Germany
[4] Univ Med Ctr Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany
[5] Univ Med Ctr Regensburg, Dept Pathol, D-93053 Regensburg, Germany
基金
美国国家卫生研究院;
关键词
ESTABLISHED EXPERIMENTAL COLITIS; TOLL-LIKE RECEPTOR; PROTEIN-KINASE; BOWEL-DISEASE; MURINE MODEL; INDUCTION; FIBROSIS; CELLS; GSK3; ANTIBODIES;
D O I
10.4049/jimmunol.1301072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Spontaneous amelioration of inflammation (often accompanied by fibrosis) is a well-known, but poorly understood, outcome of many chronic inflammatory processes. We studied this phenomenon in a chronic trinitrobenzene sulfonic acid-induced colitis model, an experimental colitis in mice that we showed to ultimately undergo spontaneous resolution, despite continued trinitrobenzene sulfonic acid stimulation. Analysis of the mechanism of this resolution revealed that it was critically dependent on IL-13 activation of STAT6, followed by phosphorylation (inactivation) of glycogen synthase kinase-3 delta, at least in part via STAT6 induction of p38 MAPK. Such glycogen synthase kinase-3 delta inactivation causes changes in CREB and p65 DNA-binding activity that favors decreased proinflammatory IL-17 production and increased anti-inflammatory IL-10 production. Thus, in this case, IL-13 acts as a molecular switch that leads to resolution of inflammation.
引用
收藏
页码:3969 / 3980
页数:12
相关论文
共 41 条
[1]
The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[2]
Growth factors in inflammatory bowel disease [J].
Beck, PL ;
Podolsky, DK .
INFLAMMATORY BOWEL DISEASES, 1999, 5 (01) :44-60
[3]
Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 [J].
Boirivant, M ;
Fuss, IJ ;
Chu, A ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1929-1939
[4]
A Transient Breach in the Epithelial Barrier Leads to Regulatory T-Cell Generation and Resistance to Experimental Colitis [J].
Boirivant, Monica ;
Amendola, Antonello ;
Butera, Alessia ;
Sanchez, Massimo ;
Xu, Lili ;
Marinaro, Mariarosaria ;
Kitani, Atsushi ;
Di Giacinto, Claudia ;
Strober, Warren ;
Fuss, Ivan J. .
GASTROENTEROLOGY, 2008, 135 (05) :1612-1623
[5]
The immunological and genetic basis of inflammatory bowel disease [J].
Bouma, G ;
Strober, W .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) :521-533
[6]
Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis [J].
Carter, Natalie A. ;
Rosser, Elizabeth C. ;
Mauri, Claudia .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (01)
[7]
The renaissance of GSK3 [J].
Cohen, P ;
Frame, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :769-776
[8]
Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392
[9]
Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides [J].
Fichtner-Feigl, S ;
Fuss, IJ ;
Preiss, JC ;
Strober, W ;
Kitani, A .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3057-3071
[10]
IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis [J].
Fichtner-Feigl, S ;
Strober, W ;
Kawakami, K ;
Puri, RK ;
Kitani, A .
NATURE MEDICINE, 2006, 12 (01) :99-106